Page 77 - Read Online
P. 77

Siddiqui et al. Chem Synth 2023;3:25  https://dx.doi.org/10.20517/cs.2023.02    Page 23 of 50


























                Figure 38. Microbial transformation of oxandrolone (184) with Cunninghamella  blakesleeana, M. phaseolina, Glomerella fusarioides, and
                Rhizopus stolonifer.

               197-202  were  found  to  be  new   [Figure 39]. Compounds  194, 196, 199, 200, 201, and  202  showed
                                             [61]
               significant anti-inflammatory activity with the IC  values of 202, 117, 250, 183, 295, 50, and 127 μM,
                                                           50
               respectively, as compared to the standard drug prednisolone (IC  = 83 μM). Metabolite 195 was found to be
                                                                     50
               inactive .
                      [61]
               Similarly, Cunninghamella blakesleeana-mediated fermentation of mesterolone (194) (0.60%) yielded seven
               new compounds, 1α-methyl-11β, 14α, 17β-trihydroxy-5α-androstan-3-one (204), 1α-methyl-7β, 17β-
               dihydroxy-5α-androstan-3-one (205) (0.70%), 1α-methyl-17β-hydroxy-5α-androstan-3, 7-dione (206) (1.0%)
               [62]  [Figure 40], 1α-methyl-1β, 11α, 17β-trihydroxy-5α-androstan-3-one (207) (0.90%), 1α-methyl-7α, 11β,17β-
               trihydroxy-5α-androstan-3-one (208) (0.40%), 1α-methyl-1β, 6α, 17β-trihydroxy-5α-androstan-3-one (209)
               (0.40%), and 1α-methyl-1β, 11β, 17β-trihydroxy-5α-androstan-3-one (210) (0.50%), along with three known
                                          [63]
               metabolites, 197, 198, and 199  [Figure 40]. Fermentation of mesterolone (194) with Macrophomina
               phaseolina afforded the new compound, 1α-methyl, 17β-hydroxy-5α-androstan-3, 6-dione (211) (0.40%)
                                                                                                        [63]
               [Figure 40].

               Biotransformation of mibolerone (212)
               Mibolerone (212) is a potent synthetic anabolic steroid, marketed by Upjohn Company (USA) under the
               brand name Cheque Drops, for the treatment of estrous (heat) in female dogs. Biotransformation of
               mibolerone  (212)  was  carried  out  at  room  temperature  using  Cunninghamella  echinulata, and
               Macrophomina phaseolina. This afforded six new metabolites, 10β, 17β-dihydroxy-7α, 17α-dimethylestr-4-
               en-3-one (213) (4.0%), 6 , 17 -dihydroxy-7 , 17 -dimethylestr-4-en-3-one (214) (2.0%), 6 , 10 , 17 -
               trihydroxy-7 , 17 -dimethylestr-4-en-3-one (215) (30.0%), 11β, 17β, 20-trihydroxy-7α, 17α-dimethylestr-4-
               en-3-one (216) (0.4%), 1α, 17β-dihydroxy-7α, 17α-dimethylestr-4-en-3-one (217) (0.24%), 1α, 11β, 17β-
               trihydroxy-7α, 17α-dimethylestr-4-en-3-one (218) (0.34%), and a known metabolite, 11β, 17β-dihydroxy-7α,
                                                   [64]
               17α-dimethylestr-4-ene-3-one (219) (3.0%)  [Figure 41].
               Biotransformation of metenolone acetate (220)
               Metenolone acetate (220) is another synthetic steroidal anabolic drug, sold under the brand names Nibal
               and Primobolan Depot, for the treatment of anemia. Drug 220 is also used by athletes, and for sports
               animals, to enhance their muscular strength and physical performances. Microbial transformation of
   72   73   74   75   76   77   78   79   80   81   82